Genetic Analysis Solutions for Biopharma Process Development

Streamline process development with authenticated cell lines and known sources of potential contamination. Gene expression and dPCR enable highly specific and sensitive detection, identification, and quantitation of microbial strains and residual vector DNA. Allelic discrimination is a straightforward approach to assess cell lines for authenticity, provenance, and long-term genetic stability.

Microbial identification

Detect microbial targets at the lowest limits, even in the presence of common inhibitors, to help produce microbe-free drugs and therapeutics with confidence.

Learn more about our microbial detection kit ›

Residual vector quantification

Quantify absolute viral vector titers in your cell cultures to determine concentrations of your biotherapeutic for use in gene and cell therapies.

Learn about our dPCR solutions ›

Cell line quality control

Speed development of new approaches to cell-based therapeutics with authenticated cell lines and confirm the identity of your human cultured cells with confidence with short tandem repeat (STR) genotyping.

Explore out STR solutions ›

Resources

Poster: PCR system for consistent viral titer quantification

Learn how the increased robustness and consistency possible with our dPCR microfluidic array plate (MAP) technology improves AAV viral titer quantification.

Download poster ›

Discovery

Screening

Clinical trials

Manufacturing

QualTrak digital experience

Discover QualTrak qPCR and dPCR workflows for mAbs, vaccines, and cell and gene therapies across biopharmaceutical development and manufacturing.

Explore now ›

Monoclonal antibody development

Efficiently develop and characterize recombinant monoclonal antibodies (mAbs) from discovery through clinical trials and manufacturing by incorporating genetic-level analysis into your workflows.

Learn more ›